Comparison of Anti-Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis.

ABSTRACT:

SUBMITTER: Maiorano BA 

PROVIDER: S-EPMC10196874 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature